Literature DB >> 11491152

Changes in bronchial inflammation during acute exacerbations of chronic bronchitis.

S Gompertz1, C O'Brien, D L Bayley, S L Hill, R A Stockley.   

Abstract

There are little data describing noncellular changes in bronchial inflammation during exacerbations of chronic bronchitis. The relationship between sputum colour and airway inflammation at presentation has been assessed during an exacerbation in patients with chronic bronchitis and a primary care diagnosis of chronic obstructive pulmonary disease. Sputum myeloperoxidase, neutrophil elastase, leukotriene B4 (LTB4), interleukin-8 (IL-8), sol:serum albumin ratio and serum C-reactive protein were measured in patients presenting with an exacerbation and mucoid (n = 27) or purulent sputum (n = 42). Mucoid exacerbations were associated with little bronchial or systemic inflammation at presentation, and sputum bacteriology was similar to that obtained in the stable state. Purulent exacerbations were associated with marked bronchial and systemic inflammation (p < 0.025 for all features) and positive sputum cultures (90%). Resolution was related to a significant reduction in LTB4 (p < 0.01), but no change in IL-8, suggesting that LTB4 may be more important in neutrophil recruitment in these mild, purulent exacerbations. In the stable state, IL-8 remained higher in patients who had experienced a purulent exacerbation (2p < 0.02). The presented results indicate that exacerbations of chronic bronchitis, defined by sputum colour, differ in the degree of bronchial and systemic inflammation. Purulent exacerbations are related to bacterial infection, and are associated with increased neutrophilic inflammation and increased leukotriene B4 concentrations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11491152     DOI: 10.1183/09031936.01.99114901

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  66 in total

1.  Exposing rodents to a combination of tobacco smoke and lipopolysaccharide results in an exaggerated inflammatory response in the lung.

Authors:  E L Hardaker; M S Freeman; N Dale; P Bahra; F Raza; K H Banner; C Poll
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 2.  COPD exacerbations . 2: aetiology.

Authors:  E Sapey; R A Stockley
Journal:  Thorax       Date:  2006-03       Impact factor: 9.139

3.  Correlation between decrease of CRP and resolution of airway inflammatory response, improvement of health status, and clinical outcomes during severe acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Ying Liang; Chun Chang; Hong Zhu; Ning Shen; Bei He; Wanzhen Yao
Journal:  Intern Emerg Med       Date:  2015-03-31       Impact factor: 3.397

Review 4.  New concepts in the pathobiology of chronic obstructive pulmonary disease.

Authors:  Victor Kim; Thomas J Rogers; Gerard J Criner
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

5.  Human rhinovirus 1B exposure induces phosphatidylinositol 3-kinase-dependent airway inflammation in mice.

Authors:  Dawn C Newcomb; Umadevi S Sajjan; Deepti R Nagarkar; Qiong Wang; Suparna Nanua; Ying Zhou; Christina L McHenry; Kenneth T Hennrick; Wan C Tsai; J Kelley Bentley; Nicholas W Lukacs; Sebastian L Johnston; Marc B Hershenson
Journal:  Am J Respir Crit Care Med       Date:  2008-02-14       Impact factor: 21.405

6.  Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis.

Authors:  A J White; S Gompertz; D L Bayley; S L Hill; C O'Brien; I Unsal; R A Stockley
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

7.  Cigarette smoke increases BLT2 receptor functions in bronchial epithelial cells: in vitro and ex vivo evidence.

Authors:  Elisabetta Pace; Maria Ferraro; Serena Di Vincenzo; Andreina Bruno; Antonino Giarratano; Valeria Scafidi; Luana Lipari; Denise Valentina Di Benedetto; Serafina Sciarrino; Mark Gjomarkaj
Journal:  Immunology       Date:  2013-06       Impact factor: 7.397

8.  Eosinopenia as a Marker of Outcome in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

Authors:  Mohammad Hossein Rahimi-Rad; Behzad Asgari; Negar Hosseinzadeh; Ali Eishi
Journal:  Maedica (Buchar)       Date:  2015-03

Review 9.  Role of macrolide therapy in chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez; Jeffrey L Curtis; Richard Albert
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

10.  PKA and Epac cooperate to augment bradykinin-induced interleukin-8 release from human airway smooth muscle cells.

Authors:  Sara S Roscioni; Loes E M Kistemaker; Mark H Menzen; Carolina R S Elzinga; Reinoud Gosens; Andrew J Halayko; Herman Meurs; Martina Schmidt
Journal:  Respir Res       Date:  2009-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.